Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

620 ARTÍCULOS , VIENDO DEL 316 AL 330

Block copolymers in Alzheimer's disease therapy: A perceptive to revolutionize biomaterials

Revdekar A, Shende P.

J Control Release. 2021 Dec 10;340:271-281. doi: 10.1016/j.jconrel.2021.11.007. Epub 2021 Nov 8.

Pursuit of precision medicine: Systems biology approaches in Alzheimer's disease mouse models

Gurdon B, Kaczorowski C.

Neurobiol Dis. 2021 Dec;161:105558. doi: 10.1016/j.nbd.2021.105558. Epub 2021 Nov 10.

Disentangling Mitochondria in Alzheimer's Disease

Johri A.

Int J Mol Sci. 2021 Oct 26;22(21):11520. doi: 10.3390/ijms222111520.

Alzheimer's Disease and Diabetes Mellitus in Comparison: The Therapeutic Efficacy of the Vanadium Compound

He Z, You G, Liu Q, Li N.

Int J Mol Sci. 2021 Nov 3;22(21):11931. doi: 10.3390/ijms222111931.

Huperzine A and Its Neuroprotective Molecular Signaling in Alzheimer's Disease

Friedli MJ, Inestrosa NC.

Molecules. 2021 Oct 29;26(21):6531. doi: 10.3390/molecules26216531.

Antisense oligonucleotides for Alzheimer's disease therapy: from the mRNA to miRNA paradigm

Grabowska-Pyrzewicz W, Want A, Leszek J, Wojda U.

EBioMedicine. 2021 Dec;74:103691. doi: 10.1016/j.ebiom.2021.103691. Epub 2021 Nov 10.

Recent advances in molecular pathways and therapeutic implications targeting neuroinflammation for Alzheimer's disease

Dhapola R, Hota SS, Sarma P, Bhattacharyya A, Medhi B, Reddy DH.

Inflammopharmacology. 2021 Dec;29(6):1669-1681. doi: 10.1007/s10787-021-00889-6. Epub 2021 Nov 23.

Alzheimer Disease and Sleep Disorders: Insights into the Possible Disease Connections and the Potential Therapeutic Targets (Part I)

Bahbah EI, Kamal MA.

CNS Neurol Disord Drug Targets. 2021;20(7):572-573. doi: 10.2174/187152732007210909150558.

Advanced Nanoparticular Approaches to Combat Alzheimer's Disease

Shah R, Bhattacharya S.

Pharm Nanotechnol. 2021;9(5):308-316. doi: 10.2174/2211738509666211123091913.

Pharmacological Medical Treatment of Epilepsy in Patients with Dementia: A Systematic Review

Musaeus CS, Nilsson C, Cooper C, Kramberger MG, Verdelho A, Stefanova E, Religa D, Waldemar G, Frederiksen KS.

Curr Alzheimer Res. 2021;18(9):689-694. doi: 10.2174/1567205018666211126121529.

Significance of GABA(A) Receptor for Cognitive Function and Hippocampal Pathology

Sakimoto Y, Oo PM, Goshima M, Kanehisa I, Tsukada Y, Mitsushima D.

Int J Mol Sci. 2021 Nov 18;22(22):12456. doi: 10.3390/ijms222212456.

Therapeutic Potential of Mitophagy-Inducing Microflora Metabolite, Urolithin A for Alzheimer's Disease

Jayatunga DPW, Hone E, Khaira H, Lunelli T, Singh H, Guillemin GJ, Fernando B, Garg ML, Verdile G, Martins RN.

Nutrients. 2021 Oct 23;13(11):3744. doi: 10.3390/nu13113744.

Alzheimer Disease and Sleep Disorders: Insights into the Possible Disease Connections and the Potential Therapeutic Targets (Part II)

Kamal MA, Bahbah EI.

CNS Neurol Disord Drug Targets. 2021;20(8):674-676. doi: 10.2174/187152732008210921121240.

Impact of Donepezil and Memantine on Behavioral and Psychological Symptoms of Alzheimer Disease: Six-month Open-label Study

Bago Rožanković P, Rožanković M, Badžak J, Stojić M, Šušak Sporiš I.

Cogn Behav Neurol. 2021 Dec 2;34(4):288-294. doi: 10.1097/WNN.0000000000000285.

Cholinesterase inhibitors and memantine for the treatment of Alzheimer and non-Alzheimer dementias

Balázs N, Bereczki D, Kovács T.

Ideggyogy Sz. 2021 Nov 30;74(11-12):379-387. doi: 10.18071/isz.74.0379.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias